Arbutus Biopharma Inc.
The UBC Department of Pathology and Laboratory Medicine offers a remarkable opportunity to study with numerous world renowned faculty and research programs. We are recognized as national and international leaders in both basic and clinical research. Experimental Pathology refers to research in any area of biomedical investigation that is relevant to human disease. Since it is necessary to understand the normal working of the system to fully define the changes associated with disease, the areas represented at UBC cover a wide range of fields and approaches. Work at all levels of biological organization is involved, from protein to lipoprotein biochemistry and molecular biology through cell and tumour biology, animal models for studies on pulmonary and cardiovascular pathophysiology and viral and bacterial infection processes, to clinical studies on human population and the AIDS epidemic.
We train students with varied backgrounds in science and medicine including: biochemistry, physiology, cell biology and microbiology/immunology.
We are committed to effective, cutting-edge, ethical research. The results of which will reach beyond the academic realm to effect positive change in the lives of our families, communities and, ultimately, our world.
The Faculty of Graduate and Postdoctoral Studies establishes the minimum admission requirements common to all applicants, usually a minimum overall average in the B+ range (76% at UBC). The graduate program that you are applying to may have additional requirements. Please review the specific requirements for applicants with credentials from institutions in:
Each program may set higher academic minimum requirements. Please review the program website carefully to understand the program requirements. Meeting the minimum requirements does not guarantee admission as it is a competitive process.
Applicants from a university outside Canada in which English is not the primary language of instruction must provide results of an English language proficiency examination as part of their application. Tests must have been taken within the last 24 months at the time of submission of your application.
Minimum requirements for the two most common English language proficiency tests to apply to this program are listed below:
Overall score requirement: 100
Overall score requirement: 7.0
Some programs require additional test scores such as the Graduate Record Examination (GRE) or the Graduate Management Test (GMAT). The requirements for this program are:
The GRE is required by some applicants. Please check the program website.
All applicants have to submit transcripts from all past post-secondary study. Document submission requirements depend on whether your institution of study is within Canada or outside of Canada.
A minimum of three references are required for application to graduate programs at UBC. References should be requested from individuals who are prepared to provide a report on your academic ability and qualifications.
Many programs require a statement of interest, sometimes called a "statement of intent", "description of research interests" or something similar.
Students in research-based programs usually require a faculty member to function as their supervisor. Please follow the instructions provided by each program whether applicants should contact faculty members.
Permanent Residents of Canada must provide a clear photocopy of both sides of the Permanent Resident card.
All applicants must complete an online application form and pay the application fee to be considered for admission to UBC.
|Fees||Canadian Citizen / Permanent Resident / Refugee / Diplomat||International|
|Installments per year||3||3|
|Tuition per installment||$1,802.52||$3,166.73|
|Tuition per year|
(plus annual increase, usually 2%-5%)
|Int. Tuition Award (ITA) per year (if eligible)||$3,200.00 (-)|
|Other Fees and Costs|
|Student Fees (yearly)||$1,081.64 (approx.)|
|Costs of living (yearly)||starting at $18,517.90 (check cost calculator)|
Applicants to UBC have access to a variety of funding options, including merit-based (i.e. based on your academic performance) and need-based (i.e. based on your financial situation) opportunities.
All full-time students who begin a UBC-Vancouver PhD program in September 2021 or later will be provided with a funding package of at least $24,000 for each of the first five years of their PhD. The funding package may consist of any combination of internal or external awards, teaching-related work, research assistantships, and graduate academic assistantships. In addition, the Program provides tuition funding of $2,000.00 per year for each of the first five years of the PhD. Please note that some graduate programs provide funding packages that are greater than $26,000 total per year. Please check with your prospective graduate program for specific details of the funding provided to its PhD students.
All applicants are encouraged to review the awards listing to identify potential opportunities to fund their graduate education. The database lists merit-based scholarships and awards and allows for filtering by various criteria, such as domestic vs. international or degree level.
Graduate programs may have Teaching Assistantships available for registered full-time graduate students. Full teaching assistantships involve 12 hours work per week in preparation, lecturing, or laboratory instruction although many graduate programs offer partial TA appointments at less than 12 hours per week. Teaching assistantship rates are set by collective bargaining between the University and the Teaching Assistants' Union.
Many professors are able to provide Research Assistantships (GRA) from their research grants to support full-time graduate students studying under their direction. The duties usually constitute part of the student's graduate degree requirements. A Graduate Research Assistantship is a form of financial support for a period of graduate study and is, therefore, not covered by a collective agreement. Unlike other forms of fellowship support for graduate students, the amount of a GRA is neither fixed nor subject to a university-wide formula. The stipend amounts vary widely, and are dependent on the field of study and the type of research grant from which the assistantship is being funded. Some research projects also require targeted research assistance and thus hire graduate students on an hourly basis.
Canadian and US applicants may qualify for governmental loans to finance their studies. Please review eligibility and types of loans.
All students may be able to access private sector or bank loans.
Many foreign governments provide support to their citizens in pursuing education abroad. International applicants should check the various governmental resources in their home country, such as the Department of Education, for available scholarships.
The possibility to pursue work to supplement income may depend on the demands the program has on students. It should be carefully weighed if work leads to prolonged program durations or whether work placements can be meaningfully embedded into a program.
Canadian residents with RRSP accounts may be able to use the Lifelong Learning Plan (LLP) which allows students to withdraw amounts from their registered retirement savings plan (RRSPs) to finance full-time training or education for themselves or their partner.
Please review Filing taxes in Canada on the student services website for more information.
Applicants have access to the cost calculator to develop a financial plan that takes into account various income sources and expenses.
85 students graduated between 2005 and 2013: 1 graduate is seeking employment; for 8 we have no data (based on research conducted between Feb-May 2016). For the remaining 76 graduates:
These statistics show data for the Doctor of Philosophy in Pathology and Laboratory Medicine (PhD). Data are separated for each degree program combination. You may view data for other degree options in the respective program profile.
|2010||Dr. Kalra suggests that by evaluating multiple endpoints to assess the therapeutic effects of targeted drugs in vitro and in vivo, we can better predict their performance in clinical trials. These studies showed that molecular targeting strategies involving a protein called Integrin Linked Kinase could be beneficial in the treatment of breast cancers.|
|2010||Dr. Wilson studied the DNA of lung cancer cells to identify new genes associated with familial risk, drug response, and survival. His research involved the use of novel techniques and yielded results that are significant not only to the research community, but to lung-cancer patients as well.|
|2010||Dr. Lee investigated how natural killer cells prevent type 1 diabetes. Her works showed that this subset of cells is important for the immune system to suppress the development of autoimmunity. She further demonstrated that these cells can be manipulated into activity, inducing a protective mechanism that prevents onset of type 1 diabetes.|
|2010||Dr. Le studied the biophysical mechanisms responsible for the immunocamouflage of transplanted cells by the covalent attachment of non-immunogenic and non-toxic polymer chains. This research is imperative in designing safe and efficient technology for the prevention of donor tissue rejection in transfusion and transplantation medicine.|
|2010||Dr. Shadeo's work in the genomic evaluation of precancerous lesions of breast and cervix has lead to the identification of aberrant genes and gene networks not previously implicated in cancer progression. These comparative studies revealed that multiple components of a key biological gene network can be altered in disease development.|
|2010||Dr. Prystajecky's research focused on developing molecular epidemiological tools to assess the health risk potential of waterborne protozoa. These tools were successfully integrated into routine water testing and contributed to knowledge regarding pathogen dynamics in watersheds. Her work will have significant impact on drinking water surveillance and public health policy.|
|2010||Dr. Liu studied the role of chemokines in the migration of immune cells across the monolayer of endothelial cells that line the cerebral blood vessels. He showed that unique chemokine-receptor interactions mediate the binding and migration of specific immune cell subsets across activated endothelium to initiate central nervous system inflammation.|
|2010||Dr. Lin identified a new prostate cancer metastasis-related gene, ASAP1. He showed that increased expression of this gene is associated with prostate cancer metastasis in animal model systems and in clinical cases. This study assists us in the understanding of metastasis mechanisms and provides a potential biomarker and therapeutic target for the disease.|
|2010||Dr. Tavassoli found a new co-activator protein that binds to and differentially enhances androgen receptor activity. He also developed cell-based screening assays for agents that modulate growth, death and androgen receptor activation in prostate cancer cells. He subsequently applied his method to find more potent drugs against receptor activity.|
|2009||Dr. Yang investigated the possible mechanistic roles of the enzyme lipoprotein-associated phospholipase A2 in regard to its association with cardiovascular disease. Specifically, the results of his work describe the influence of this enzyme on lipid and lipoprotein metabolism in human cell culture systems.|
Experimental Pathology refers to research in any area of biomedical investigation that is relevant to human disease. Since it is necessary to understand the normal working of the system to fully define the changes associated with disease, the areas represented at UBC cover a wide range of fields and approaches. Work at all levels of biological organization is involved, from protein to lipoprotein biochemistry and molecular biology through cell and tumour biology, animal models for studies on pulmonary and cardiovascular pathophysiology and viral and bacterial infection processes, to clinical studies on human population and the AIDS epidemic.